Annual CFO
-$12.74 M
+$4.07 M+24.21%
December 31, 2023
Summary
- As of February 7, 2025, ALLR annual cash flow from operations is -$12.74 million, with the most recent change of +$4.07 million (+24.21%) on December 31, 2023.
- During the last 3 years, ALLR annual CFO has fallen by -$5.49 million (-75.77%).
- ALLR annual CFO is now -75.77% below its all-time high of -$7.25 million, reached on December 31, 2020.
Performance
ALLR Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$5.44 M
+$1.77 M+24.57%
September 1, 2024
Summary
- As of February 7, 2025, ALLR quarterly cash flow from operations is -$5.44 million, with the most recent change of +$1.77 million (+24.57%) on September 1, 2024.
- Over the past year, ALLR quarterly CFO has dropped by -$3.96 million (-266.04%).
- ALLR quarterly CFO is now -266.04% below its all-time high of -$1.49 million, reached on March 1, 2024.
Performance
ALLR Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$15.82 M
-$67.00 K-0.43%
September 1, 2024
Summary
- As of February 7, 2025, ALLR TTM cash flow from operations is -$15.82 million, with the most recent change of -$67.00 thousand (-0.43%) on September 1, 2024.
- Over the past year, ALLR TTM CFO has dropped by -$4.79 million (-43.40%).
- ALLR TTM CFO is now -228.72% below its all-time high of -$4.81 million, reached on September 30, 2020.
Performance
ALLR TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
ALLR Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +24.2% | -266.0% | -43.4% |
| 3 y3 years | -75.8% | -266.0% | -43.4% |
| 5 y5 years | -26.0% | -266.0% | -43.4% |
ALLR Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +24.2% | -266.0% | +24.6% | -43.4% | +15.4% |
| 5 y | 5-year | -75.8% | +24.2% | -266.0% | +24.6% | -228.7% | +15.4% |
| alltime | all time | -75.8% | +24.2% | -266.0% | +24.6% | -228.7% | +15.4% |
Allarity Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$5.44 M(-24.6%) | -$15.82 M(+0.4%) |
| Jun 2024 | - | -$7.22 M(+385.3%) | -$15.75 M(+42.8%) |
| Mar 2024 | - | -$1.49 M(-11.1%) | -$11.03 M(-13.4%) |
| Dec 2023 | -$12.74 M(-24.2%) | -$1.67 M(-68.9%) | -$12.74 M(-5.7%) |
| Sep 2023 | - | -$5.38 M(+115.4%) | -$13.52 M(+7.7%) |
| Jun 2023 | - | -$2.50 M(-22.0%) | -$12.55 M(-12.0%) |
| Mar 2023 | - | -$3.20 M(+30.9%) | -$14.26 M(-15.2%) |
| Dec 2022 | -$16.82 M | -$2.45 M(-44.5%) | -$16.82 M(-10.0%) |
| Sep 2022 | - | -$4.41 M(+4.8%) | -$18.69 M(+3.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$4.21 M(-26.9%) | -$18.02 M(-0.3%) |
| Mar 2022 | - | -$5.75 M(+33.2%) | -$18.07 M(+21.4%) |
| Dec 2021 | -$14.89 M(+105.3%) | -$4.32 M(+15.7%) | -$14.89 M(+40.9%) |
| Sep 2021 | - | -$3.73 M(-12.5%) | -$10.57 M(-9.3%) |
| Jun 2021 | - | -$4.27 M(+66.2%) | -$11.64 M(+57.8%) |
| Mar 2021 | - | -$2.57 M(-46.7%) | -$7.38 M(+53.3%) |
| Dec 2020 | -$7.25 M(-28.3%) | - | - |
| Sep 2020 | - | -$4.81 M | -$4.81 M |
| Dec 2019 | -$10.11 M | - | - |
FAQ
- What is Allarity Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Allarity Therapeutics?
- What is Allarity Therapeutics annual CFO year-on-year change?
- What is Allarity Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Allarity Therapeutics?
- What is Allarity Therapeutics quarterly CFO year-on-year change?
- What is Allarity Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Allarity Therapeutics?
- What is Allarity Therapeutics TTM CFO year-on-year change?
What is Allarity Therapeutics annual cash flow from operations?
The current annual CFO of ALLR is -$12.74 M
What is the all time high annual CFO for Allarity Therapeutics?
Allarity Therapeutics all-time high annual cash flow from operations is -$7.25 M
What is Allarity Therapeutics annual CFO year-on-year change?
Over the past year, ALLR annual cash flow from operations has changed by +$4.07 M (+24.21%)
What is Allarity Therapeutics quarterly cash flow from operations?
The current quarterly CFO of ALLR is -$5.44 M
What is the all time high quarterly CFO for Allarity Therapeutics?
Allarity Therapeutics all-time high quarterly cash flow from operations is -$1.49 M
What is Allarity Therapeutics quarterly CFO year-on-year change?
Over the past year, ALLR quarterly cash flow from operations has changed by -$3.96 M (-266.04%)
What is Allarity Therapeutics TTM cash flow from operations?
The current TTM CFO of ALLR is -$15.82 M
What is the all time high TTM CFO for Allarity Therapeutics?
Allarity Therapeutics all-time high TTM cash flow from operations is -$4.81 M
What is Allarity Therapeutics TTM CFO year-on-year change?
Over the past year, ALLR TTM cash flow from operations has changed by -$4.79 M (-43.40%)